Continuing renewed approval is required at least annually for research that requires review by the convened IRB, unless it meets the criteria listed below. The IRB may require additional review at more frequent intervals if the assessment of risk warrants it.
Unless the IRB determines otherwise, continuing renewed approval is not required for:
Modifications, reportable events (e.g. unanticipated problems involving risks to subjects or others, noncompliance) and study closure must still be submitted to the IRB, even if the study does not require continuing renewed approval. The IRB will also typically require a status check to determine if the human subject research activities are still ongoing or if the study could be closed.
The IRB will include whether renewed continuing review is required in the IRB approval letter.
IRB approval is valid for a maximum period of one year. However, the IRB may require additional review at more frequent intervals if the assessment of risk warrants it.
Principal investigators (PI) who would like to continue non-exempt human research and/or a clinical investigation beyond the expiration of IRB approval must receive renewed approval prior to the research study’s expiration. The approval period will be listed on approval letters sent to researchers, including both the approval date and the approval end (expiration) date.
Continuing review is required as long as remaining activities involve human subject research, including data collection, analysis of identifiable private information or identifiable biospecimens, or follow-up of subjects, even when the research is permanently closed to the enrollment of new subjects and all subjects have completed all research-related interventions.
All human research activities, including analysis of private identifiable information, identifiable biospecimens, or enrollment of new subjects, must stop upon expiration of the research approval, unless the IRB finds an overriding safety concern or it is in the best interest of the currently enrolled subjects to continue. Therefore, it is important to submit the request for continuing review at least three to four weeks prior to expiration to allow adequate time for review and approval by the IRB.
The PI is responsible for submitting a request for continued approval before the project expires. Requests for Continuing Review are made through the ClickTM Research Compliance System.
Available at the Click Templates page.
Available at the Click Quick Guides & Videos page.
For more information, visit HRPP Manual 8-7, Renewed Approval.